FI60216C - Biologiskt aktivt vid affinitetsreaktioner anvaendbart adsorptionsmedel - Google Patents

Biologiskt aktivt vid affinitetsreaktioner anvaendbart adsorptionsmedel Download PDF

Info

Publication number
FI60216C
FI60216C FI751299A FI751299A FI60216C FI 60216 C FI60216 C FI 60216C FI 751299 A FI751299 A FI 751299A FI 751299 A FI751299 A FI 751299A FI 60216 C FI60216 C FI 60216C
Authority
FI
Finland
Prior art keywords
polyhydroxymethylene
biologically active
washed
solution
water
Prior art date
Application number
FI751299A
Other languages
English (en)
Finnish (fi)
Other versions
FI751299A (es
FI60216B (fi
Inventor
Rudolf Schmidtberger
Heinrich Huemer
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742421789 external-priority patent/DE2421789C3/de
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI751299A publication Critical patent/FI751299A/fi
Priority to FI783694A priority Critical patent/FI61811C/fi
Application granted granted Critical
Publication of FI60216B publication Critical patent/FI60216B/fi
Publication of FI60216C publication Critical patent/FI60216C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
FI751299A 1974-05-06 1975-04-30 Biologiskt aktivt vid affinitetsreaktioner anvaendbart adsorptionsmedel FI60216C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI783694A FI61811C (fi) 1974-05-06 1978-12-01 Anvaendning av en biologiskt aktiv produkt bestaoende av en i atten oloeslig baerare och ett biologiskt aktivt aemne sa osm adsorptionsmedel foer affinitetskromatografi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2421789 1974-05-06
DE19742421789 DE2421789C3 (de) 1974-05-06 Biologisch aktive Produkte und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
FI751299A FI751299A (es) 1975-11-07
FI60216B FI60216B (fi) 1981-08-31
FI60216C true FI60216C (fi) 1981-12-10

Family

ID=5914739

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751299A FI60216C (fi) 1974-05-06 1975-04-30 Biologiskt aktivt vid affinitetsreaktioner anvaendbart adsorptionsmedel

Country Status (16)

Country Link
JP (1) JPS599153B2 (es)
AT (1) AT338417B (es)
BE (1) BE828776A (es)
CA (1) CA1063049A (es)
CH (1) CH630410A5 (es)
DK (1) DK196175A (es)
ES (1) ES437153A1 (es)
FI (1) FI60216C (es)
FR (1) FR2270266B1 (es)
GB (1) GB1512651A (es)
IE (1) IE41040B1 (es)
IT (1) IT1054620B (es)
LU (1) LU72407A1 (es)
NL (1) NL181782C (es)
NO (1) NO144672C (es)
SE (2) SE427086B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2552510C3 (de) * 1975-11-22 1981-02-19 Behringwerke Ag, 3550 Marburg Biologisch aktive Verbindungen und Verfahren zu ihrer Herstellung
EP1585817B1 (en) * 2002-02-20 2009-09-02 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
JP6476934B2 (ja) * 2015-02-02 2019-03-06 東ソー株式会社 新規重合体、およびそれを有する細胞培養基材

Also Published As

Publication number Publication date
FR2270266A1 (es) 1975-12-05
LU72407A1 (es) 1977-02-09
CA1063049A (en) 1979-09-25
IE41040B1 (en) 1979-10-10
BE828776A (fr) 1975-11-06
FI751299A (es) 1975-11-07
NO144672C (no) 1981-10-14
NO144672B (no) 1981-07-06
FI60216B (fi) 1981-08-31
JPS599153B2 (ja) 1984-02-29
FR2270266B1 (es) 1979-03-16
SE444947B (sv) 1986-05-20
NL181782C (nl) 1987-11-02
SE7505275L (sv) 1975-11-07
NL181782B (nl) 1987-06-01
ATA342275A (de) 1976-12-15
IT1054620B (it) 1981-11-30
AU8081875A (en) 1976-11-11
GB1512651A (en) 1978-06-01
CH630410A5 (en) 1982-06-15
DE2421789B2 (de) 1976-10-07
DE2421789A1 (de) 1975-11-13
AT338417B (de) 1977-08-25
NL7505152A (nl) 1975-11-10
JPS50155679A (es) 1975-12-16
NO751599L (es) 1975-11-07
ES437153A1 (es) 1977-04-16
DK196175A (da) 1975-11-07
SE427086B (sv) 1983-03-07
IE41040L (en) 1975-11-06

Similar Documents

Publication Publication Date Title
RU2175261C2 (ru) Новые аффинные лиганды и их применение
Cuatrecasas et al. [31] Affinity chromatography
US6623655B1 (en) Metal chelating compositions
Weetall et al. The chemistry and use of cellulose derivatives for the study of biological systems
US5053133A (en) Affinity separation with activated polyamide microporous membranes
ES2326834T3 (es) Marcaje de oligosacaridos en fase solida: una tecnica para la manipulacion de carbohidratos inmovilizados.
NZ609752A (en) Process for preparing maytansinoid antibody conjugates
KR19990022896A (ko) 변성 아비딘 및 스트렙트아비딘 분자 및 그 사용
GB1597758A (en) Reagent for use in assaying methods involving biospecific affinity reactions
KR101104417B1 (ko) 단백질 g 변형체를 이용한 항체의 특이적 공유결합 커플링방법
WO2000027814A1 (en) Avidin derivatives and uses thereof
AU662627B2 (en) Novel compounds and conjugates
FI60216C (fi) Biologiskt aktivt vid affinitetsreaktioner anvaendbart adsorptionsmedel
CA2519018A1 (en) The detection and identification of saxiphilins using saxitoxin-biotin conjugates
US20070010673A1 (en) Purification means
JP2011132140A (ja) 固定化タンパク質
FI61811C (fi) Anvaendning av en biologiskt aktiv produkt bestaoende av en i atten oloeslig baerare och ett biologiskt aktivt aemne sa osm adsorptionsmedel foer affinitetskromatografi
US4988625A (en) Method for determining the functionalization of a solid support
WO2007132998A1 (en) Linker molecules for substrate surface treatment and specific protein immobilization, and method for preparing the same
JP5392684B2 (ja) 固定化タンパク質の製造方法
JPS6359891A (ja) 物質の固定化方法
Pittner Immobilized biomolecules in bioanalysis
DE2421789C3 (de) Biologisch aktive Produkte und Verfahren zu ihrer Herstellung
WO2007132207A2 (en) Process for cross-linking moieties
CA2327140A1 (en) Novel protein conjugates and process for the preparation thereof

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BEHRINGWERKE AG